MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
434.50%
Quick Ratio
382.48%
Cash Ratio
103.67%
Debt to Asset Ratio
19.60%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Trade accounts receivable
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other liabi...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
110,768
196,508
163,078
158,134
Trade accounts receivable
102,119
81,758
82,448
66,761
Short-term investments
186,906
116,935
133,902
142,669
Inventory
55,590
58,376
51,678
51,710
Prepaid expenses and other assets
8,874
12,925
11,583
9,817
Total current assets
464,257
466,502
442,689
429,091
Property and equipment, net
131,464
131,394
131,112
126,650
Intangible assets, net
263,894
269,104
279,324
285,208
Operating lease right-of-use assets
43,480
44,382
45,899
48,763
Restricted cash
6,005
5,992
5,980
5,965
Long-term assets
6,431
8,291
8,166
9,271
Total assets
915,531
925,665
913,170
904,948
Accounts payable
26,211
37,450
22,159
31,237
Accrued expenses and other liabilities
77,964
88,071
111,156
87,267
Note payable - current
-
1,000
1,000
1,000
Operating lease liabilities
2,673
2,899
4,043
6,281
Total current liabilities
106,848
129,420
138,358
125,785
Operating lease liabilities - non-current
43,330
43,877
44,401
45,211
Deferred tax liabilities
29,308
30,614
31,828
31,665
Total non-current liabilities
72,638
74,491
76,229
76,876
Total liabilities
179,486
203,911
214,587
202,661
Preferred stock, value-Series APreferred Stock
-
-
-
0
Preferred stock, value
2
2
2
2
Common stock, 0.000041666 par value 650,000,000 shares authorized, 452,971,016 and 411,938,061 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
19
18
17
16
Accumulated other comprehensive income
13,078
12,650
16,440
16,103
Additional paid-in capital
3,624,836
3,563,659
3,457,654
3,389,792
Accumulated deficit
-2,901,890
-2,854,575
-2,775,530
-2,703,626
Total stockholders' equity
736,045
721,754
698,583
702,287
Total liabilities and stockholders' equity
915,531
925,665
913,170
904,948
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$186,906K (10.78%↑ Y/Y)Cash and cashequivalents$110,768K (-16.38%↓ Y/Y)Trade accountsreceivable$102,119K (70.37%↑ Y/Y)Inventory$55,590K (11.55%↑ Y/Y)Prepaid expenses andother assets$8,874K (-23.14%↓ Y/Y)Total current assets$464,257K (9.88%↑ Y/Y)Intangible assets, net$263,894K (-10.92%↓ Y/Y)Property and equipment,net$131,464K (7.34%↑ Y/Y)Operating leaseright-of-use assets$43,480K (-12.95%↓ Y/Y)Long-term assets$6,431K (-37.67%↓ Y/Y)Restricted cash$6,005K (1.03%↑ Y/Y)Total assets$915,531K (0.89%↑ Y/Y)Total liabilities andstockholders' equity$915,531K (0.89%↑ Y/Y)Total stockholders'equity$736,045K (5.38%↑ Y/Y)Total liabilities$179,486K (-14.10%↓ Y/Y)Accumulated deficit-$2,901,890K (-11.08%↓ Y/Y)Additional paid-in capital$3,624,836K (10.18%↑ Y/Y)Total currentliabilities$106,848K (-17.27%↓ Y/Y)Total non-currentliabilities$72,638K (-8.97%↓ Y/Y)Accumulated othercomprehensive income$13,078K (-37.30%↓ Y/Y)Common stock,0.000041666 par value...$19K (35.71%↑ Y/Y)Preferred stock, value$2K (0.00%↑ Y/Y)Accrued expenses andother liabilities$77,964K (-12.48%↓ Y/Y)Accounts payable$26,211K (-18.10%↓ Y/Y)Operating leaseliabilities$2,673K (-62.19%↓ Y/Y)Operating leaseliabilities - non-current$43,330K (-3.92%↓ Y/Y)Deferred tax liabilities$29,308K (-15.53%↓ Y/Y)
IOVA_BIG-svg

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

IOVA_BIG-svg

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

🚨 Price Alert: The stock price jumped by 36.18% after the earning call.